School of Medicine / Graduate School of Medicine

Uncovering Brain Intelligence Through the Integration of Neuroscience and AI

Advancing Less Invasive Cancer Treatments

The Legacy of Shibasaburo Kitasato, First Dean of the Keio University School of Medicine

Pioneering New Therapies for Treatment-Resistant Depression

Expanding Patient Access to Cancer Genomics

Drawn to the Complexity and Beauty of the Kidney

CRIK Shinanomachi: A Hub of Innovation Transforming the Future of Medicine and the World

Breakthroughs in Undiagnosed Diseases: Identifying the Causes of Diseases and Uncovering New Illnesses through Genomic Analysis

The Final Intellectual Frontier: Unraveling the Mysteries of the Brain

Studying Abroad at Johns Hopkins University: Two Third-Year Students Take on Research at One of the World's Leading Medical Schools

1: Organoid Transplantation Improves Survival in Short Bowel Syndrome Models by Providing Bile Acid Absorption Function / 2: Rethinking the Value of Atrial Fibrillation Screening — What Risks Should Be Targeted?

1: Development of a Method to Restore the Function of Lost Genes in Prader-Willi Syndrome Using Epigenome Editing Technology

1: Elucidating a New Role for "ATRX Aggregates" in Determining Neural Progenitor Cell Fate / 2: Diverse Manifestations of Sjögren's Disease Caused by Differences in Autoantibodies — Elucidating Pathogenesis through Single-Cell and Spatial Analysis —

1: Is the use of contrast media in cardiac catheterization decreasing? - Current status revealed by a registry study of over 3 million people in the US - / 2: High abundance of Lactobacillus in the vagina during early pregnancy is associated with favorable pregnancy outcomes

Discovery of Biomarkers Related to Symptoms and Treatment Response in Atopic Dermatitis: Finding New Indicators from Patient Skin to Advance Personalized Medicine

1: Molecular Understanding of Lung Cancer Heterogeneity and Identification of Novel Therapeutic Targets Using Patient-Derived Lung Cancer Organoid Libraries / 2: Design of Immune Cell Therapy with Fewer Side Effects Using Mathematical Models

1: New Technology for Direct Induction of Neurons from Blood Cells - Development of a Partial Reprogramming Method Using the NEUROD1 Gene - / 2: Brain Imaging and Post-mortem Brain Data Demonstrate Involvement of Tau Protein in Mood Disorders with Middle-age and Late-life Onset

1: Development of an Efficient Culture Method for Hepatocyte Organoids Maintaining Metabolic Functions / 2: Exploration of Kidney-Immune-Metabolic Crosstalk Originating from Tubular DNA Damage: Revealing New Intersections Between Chronic Kidney Disease and Aging

1:Distinct patterns of cognitive traits in extreme old age and Alzheimer's disease

1:Maternal circadian rhythms during pregnancy dictate metabolic plasticity in offspring